Quick Answer
Nuo Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $548.9 thousand for the year ending 2025.
- Nuo Therapeutics, Inc. showed an increase of +93.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Nuo Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2013 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2012: $2.62 million | Q2 2013: $3.37 million | Q3 2013: $4.64 million | Q2 2014: $24.97 million | Q3 2014: $20.04 million | Q1 2015: $11.82 million | Q2 2015: $6.89 million | Q3 2015: $4.05 million | Q1 2016: $685.5 thousand | Q2 2016: $6.07 million | Q3 2016: $3.88 million | Q4 2016: $2.62 million | Q1 2017: $1.34 million | Q2 2017: $331.0 thousand | Q3 2017: $1.92 million | Q1 2018: $146.9 thousand | Q2 2018: $373.3 thousand | Q3 2018: $250.2 thousand | Q4 2018: $636.9 thousand | Q1 2019: $185.3 thousand | Q2 2019: $9.0 thousand | Q3 2019: $17.3 thousand | Q3 2021: $148.4 thousand | Q1 2022: $665.4 thousand | Q2 2022: $3.44 million | Q3 2022: $2.88 million | Q1 2023: $1.25 million | Q2 2023: $344.4 thousand | Q3 2023: $582.6 thousand | Q1 2024: $366.2 thousand | Q2 2024: $473.0 thousand | Q3 2024: $683.8 thousand | Q1 2025: $55.7 thousand | Q2 2025: $316.4 thousand | Q3 2025: $514.8 thousand.
- Over the full 20 years of available data (2013 to 2025), Nuo Therapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 83.3%.
- Historical annual values: Fiscal year 2025: $548.9 thousand | Fiscal year 2024: $283.7 thousand | Fiscal year 2023: $928.7 thousand | Fiscal year 2022: $2.05 million | Fiscal year 2021: $1.41 million | Fiscal year 2021: $148.4 thousand | Fiscal year 2021: $151.6 thousand | Fiscal year 2021: $157.3 thousand | Fiscal year 2020: $161.4 thousand | Fiscal year 2020: $0.00 | Fiscal year 2020: $13.00 | Fiscal year 2020: $11.2 thousand | Fiscal year 2019: $20.3 thousand | Fiscal year 2018: $636.9 thousand | Fiscal year 2017: $693.5 thousand | Fiscal year 2016: $2.62 million | Fiscal year 2016: $10.36 million | Fiscal year 2015: $922.3 thousand | Fiscal year 2014: $15.95 million | Fiscal year 2013: $3.29 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: